WILL BUSINESS BE BETTER for AmeriPath, Inc. as a private company than it was as a publicly-traded firm? Its 2003 financial report indicates some interesting challenges, many common to all laboratories. First, a look at basic numbers. AmeriPath’s net revenues grew from $478.8 million in 2002 to $485.0 million in 2003. That’s a growth rate […]
- "Dark Index"
AmeriPath Reports on 2003, Its First Year as a Private Firm
Company reports that Quest is internalizing anatomic pathology contracts at a steady rate
- By Robert Michel
- > From the Volume XI No. 5 - April 5, 2004 Issue
- Tags: ameripath, anatomic pathologist, Anatomic pathology, cap, care contracts, dark report, ehi, Histology, hospital laboratories, impac, lab test, lab testing, laboratories, laboratory companies, laboratory industry, managed care, managed care contract, managed care contracts, pathologist compensation, pathologists, Pathology group, pathology groups, pathology practice, specialty lab, specialty laboratories, the dark report, the laboratory
